Intellinetics, Inc., a digital transformation solutions provider, recently released its financial results for the fiscal quarter ended September 30, 2024. The company reported a total revenue increase ...
Immunome Inc. (NASDAQ: IMNM), a biotechnology company specializing in targeted oncology therapies, recently disclosed its financial outcomes for the third quarter concluded on September 30, 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback